Keyphrases
Tubular Cells
100%
Apoptotic Effect
100%
Cardiorenal Syndrome
100%
Renal Tubular Epithelial Cells
63%
Heart Failure
54%
Heart Failure Patients
27%
Acute Kidney Injury
27%
Apoptosis
18%
Interleukin-6
18%
Interleukin-18 (IL-18)
18%
MRNA Expression
9%
Terminal Differentiation
9%
Three-level
9%
Hospitalization
9%
Admission Time
9%
In Vivo Exposure
9%
Protein Level
9%
DNA Fragmentation
9%
Inflammatory Cytokines
9%
Inflammatory Mediators
9%
Pathophysiology
9%
Supernatant
9%
RANTES
9%
Insults
9%
Caspase-3
9%
Acute Heart Failure
9%
Expression Profile
9%
Pathophysiological Pathways
9%
Gene Level
9%
Apoptotic Activity
9%
Mediator Release
9%
Tubular Injury
9%
Damage Markers
9%
In Vitro Cell Viability
9%
Type I Group
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiorenal Syndrome
100%
Congestive Heart Failure
72%
Acute Kidney Failure
27%
Neutrophil Gelatinase Associated Lipocalin
27%
Interleukin 6
18%
Interleukin 18
18%
Cytokine
9%
Cell Viability
9%
Caspase 3
9%
Pathophysiology
9%
Acute Heart Failure
9%
RANTES
9%
Messenger RNA
9%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Interleukin 18
22%
Interleukin 6
22%
Programmed Cell Death
22%
Cell Viability
11%
Caspase 3
11%
DNA Fragmentation
11%
Inflammatory Cytokine
11%
Mediator Release
11%
Messenger RNA
11%